The Effects of Hydroxyurea Therapy on the Six-Minute Walk Distance in Patients with Adult Sickle Cell Anemia: An Echocardiographic Study

References

• Bunn HF Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997; 337(11):762–769. doi:10.1056/NEJM1997091133711079287233
   PubMed Web of Science ®Google Scholar
• Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330(23):1639–1644. doi:10.1056/NEJM1994060933023037993409
   PubMed Web of Science ®Google Scholar
• Geiger R, Strasak A, Treml B, et al. Six-minute walk test in children and adolescents. J Pediatr. 2007; 150:395–2, 395–9. doi:10.1016/j.jpeds.2006.12.052
   Web of Science ®Google Scholar
• Minniti CP, Sable C, Campbell A, et al. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica. 2009; 94:340–347. doi:10.3324/haematol.1381219211639
   PubMed Web of Science ®Google Scholar
• Hostyn SV, de Carvalho WB, Johnston C, Braga JAP. Evaluation of functional capacity for exercise in children and adolescents with sickle cell disease through the six minute walk test. J PEDIAT BRAZIL2013 (89) 6; 588–594. doi:10.1016/j.jped.2013.04.005
   Web of Science ®Google Scholar
• Goldberg MA, Brugnara C, Dover GJ, Schapira L, Charache S, Bunn HF Treatment of sickle cell anemia with hydroxyurea and erythropoietin. Engl J Med. 1990; 323(6):366. doi:10.1056/NEJM199008093230602
   PubMed Web of Science ®Google Scholar
• Ballas SK, Dover GJ, Charache S Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo. Am J Hematol 1989; 32(2):104–111 doi:10.1002/(ISSN)1096-86522757007
   PubMed Web of Science ®Google Scholar
• Estepp JH, Smeltzer MP, Kang G, et al. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy. Am J Hematol. 2017; 92(12): 1333–1339. doi:10.1002/ajh.v92.1228913922
   PubMed Web of Science ®Google Scholar
• Yap LB, Ashrafian H, Mukerjee D, Coghlan JG, Timms PM The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension. Clin Biochem.2004; 37(10):847–856. doi:10.1016/j.clinbiochem.2004.06.00215369714
   PubMed Web of Science ®Google Scholar
• Souza R, Jardim C, Julio Cesar Fernandes C, Silveira LM, Rabelo R, Humbert M. NT-pro BNP as a tool to stratify disease severity in pulmonary arterial hypertension. Respir Med 2007; 101(1):69–75. doi:10.1016/j.rmed.2006.04.01416781131
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016; 29(4):277–314. doi:10.1016/j.echo.2016.01.01127037982
   PubMed Web of Science ®Google Scholar
• De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol. 2008; 83:19–25. doi:10.1002/(ISSN)1096-865217724699
   PubMed Web of Science ®Google Scholar
• Rees DC, Williams TN, Gladwin MT Sickle-cell disease. Lancet. 2010; 376(9757):2018–2031. doi:10.1016/S0140-6736(10)61029-X21131035
   PubMed Web of Science ®Google Scholar
• Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37:67–119.
   Google Scholar
• Nishimura RA, Schwartz RS, Tajik AJ, Holmes DR Jr. Noninvasive measurement of rate of left ventricular relaxation by Doppler echocardiography. Validation with simultaneous cardiac catheterization. Circulation. 1993; 88(1):146–155. doi:10.1161/01.CIR.88.1.1468319326
   PubMed Web of Science ®Google Scholar
• ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–117. doi:10.1164/ajrccm.166.1.at110212091180
   PubMed Web of Science ®Google Scholar
• Sahn DJ, DeMaria A, Kisslo J, Weyman A Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978; 58(6):1072–1083. doi:10.1161/01.CIR.58.6.1072709763
   PubMed Web of Science ®Google Scholar
• Otterstad JE Measuring left ventricular volume and ejection fraction with the biplane Simpson’s method. Heart. 2002; 88(6):559–560. doi:10.1136/heart.88.6.55912433875
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18(12):1440–1463. doi:10.1016/j.echo.2005.10.00516376782
   PubMed Web of Science ®Google Scholar
• Augustine DX, Coates-Bradshaw LD, Willis J, et al. Echocardiographic assessment of pulmonary hypertension: a guideline protocol from the British Society of Echocardiography. Echo Res Pract 2018; 5(3): G11–G24. doi:10.1530/ERP-17-007130012832
   PubMed Web of Science ®Google Scholar
• Appleton CP, Hatle LK, Popp RL. Superior vena cava and hepatic vein Doppler echocardiography in healthy adults. J Am Coll Cardiol. 1987; 10(5):1032–1039. doi:10.1016/S0735-1097(87)80343-13668102
   PubMed Web of Science ®Google Scholar
• Braden DS, Covitz W, Milner PF Cardiovascular function during rest and exercise in patients with sickle-cell anemia and coexisting alpha thalassemia-2.Am J Hematol. 1996; 52(2):96–102.
   Web of Science ®Google Scholar
• Moyssakis I, Tzanetea R, Tsaftaridis P, et al. Systolic and diastolic function in middle aged patients with sickle beta thalassaemia. An echocardiographic study. Postgrad Med J. 2005; 81(961):711–714. doi:10.1136/pgmj.2004.03109616272235
   PubMed Web of Science ®Google Scholar
• Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation. 2000; 102(15):1788–1794. doi:10.1161/01.CIR.102.15.178811023933
   PubMed Web of Science ®Google Scholar
• Desai AA, Patel AR, Ahmad H, et al. Mechanistic insights and characterization of sickle cell disease associated cardiomyopathy. Cardiovasc Imaging. 2014; 7:430–437. doi:10.1161/CIRCIMAGING.113.001420Circulation
   Web of Science ®Google Scholar
• Sachdev V, Machado RF, Shizukuda Y, et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol. 2007;49(4):472–479. doi:10.1016/j.jacc.2006.09.03817258093
   PubMed Web of Science ®Google Scholar
• Gladwin MT Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol. 2012;59(13):1123–33. doi: 10.1016/j.jacc.2011.10.90022440212
   PubMed Web of Science ®Google Scholar
• Niss O, Fleck R, Makue F, et al. Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. Blood. 2017; 130(2):205–213. doi:10.1182/blood-2017-02-76762428507082
   PubMed Web of Science ®Google Scholar
• Garadah T, Hassan AB, Al Alawi M, Jaradat A, Sequeira R, Qureshi F Surrogates of poor prognostic signs in adult patients with homozygous sickle cell disease: an echocardiographic study. BJMMR 2014;4(26):4431–4433. doi:10.9734/BJMMR/2014/10047
   Google Scholar
• Voskaridou E, Tsetsos G, Tsoutsias A, Spyropoulou E, Christoulas D, Terpos E Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica. 2007; 92(6):738–743. doi:10.3324/haematol.1113617550845
   PubMed Web of Science ®Google Scholar
• Machado RF, Anthi A, Steinberg MH, et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA. 2006;296(3):310–318. doi:10.1001/jama.296.3.31016849664
   PubMed Web of Science ®Google Scholar
• Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Am J Cardiol. 2006;98(4):525–529. doi:10.1016/j.amjcard.2006.02.06116893710
   PubMed Web of Science ®Google Scholar
• Waltz X, Romana M, Hardy-Dessources MD, et al. Hematological and hemorheological determinants of the six-minute walk test performance in children with sickle cell anemia. PLoS One. 2013; 8:e77830. doi: 10.1371/journal.pone.007783024147086
   PubMed Web of Science ®Google Scholar
• Gordeuk VR, Campbell A, Rana S, et al. Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease. Blood. 2009; 114:4639–4644. doi:10.1182/blood-2009-04-21804019724057
   PubMed Web of Science ®Google Scholar
• Estepp JH, Smeltzer MP, Kang G, Aygun B, Ware RE, Nottage K Higher fetal hemoglobin following escalation of hydroxyurea to maximum tolerated dose provides clinical benefit to children with sickle cell anemia. Blood. 2014; 124:8. doi:10.1182/blood.V124.21.85.85
   Web of Science ®Google Scholar
• Rodgers GP, Steinberg MH Pharmacologic treatment of sickle cell disease and thalassemia: the augmentation of fetal hemoglobin In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management (1st ed). Cambridge, UK: Cambridge University Press; 2001 p. 1028–1051.
   Google Scholar
• Badawy SM, Payne AB, Rodeghier MJ, Liem RI Exercise capacity and clinical outcomes in adults followed in the Cooperative Study of Sickle Cell Disease (CSSCD). Eur J Haematol. 2018; 101(4):532–541. doi:10.1111/ejh.2018.101.issue-429999202
   PubMed Web of Science ®Google Scholar
• Steinberg MH, Voskaridou E, Kutlar A, et al. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease. Am J Hematol. 2003; 72(2):121–126. doi:10.1002/(ISSN)1096-865212555216
   PubMed Web of Science ®Google Scholar
• Di Liberto G, Marden MC, Boyer L, et al. Dense red blood cell and oxygen desaturation in sickle-cell disease. Am J Hematol. 2016; 91(10):1008–1013. doi:10.1002/ajh.2446727380930
   PubMed Web of Science ®Google Scholar